Diffusion weighted imaging in musculoskeletal system: where are we now? [0.03%]
扩散加权成像在肌肉骨骼系统中的应用：我们目前处于什么阶段？
Sonal Saran,Avneesh Chhabra,Rajesh Botchu
Sonal Saran
Diffusion-weighted imaging (DWI) is an advanced MRI technique that harnesses the movement of water molecules within tissues to assess and characterize a wide range of musculoskeletal disorders. By differentiating between isotropic and aniso...
Sze Mun Mak,Bhavin Rawal,Giulia Benedetti et al.
Sze Mun Mak et al.
Acute pulmonary emboli can manifest as a spectrum of physiological status ranging from an incidental finding to life threatening right heart failure. We discuss the crucial role imaging plays in the accurate and rapid diagnosis. In addition...
Radiological phenotypes in pulmonary sarcoidosis: a reliability study of newly defined high-resolution computer tomography phenotypes [0.03%]
基于新型定义的高分辨率CT表型对肺部肉芽肿病放射学表型可靠性的研究
Julie Van Woensel,Jasenko Krdzalic,Tom de Jaegere et al.
Julie Van Woensel et al.
Objectives: An accurate morphological classification of distinct pulmonary phenotypes in sarcoidosis is lacking. Recently, a multinational Delphi study was conducted to reach a consensus on recognizable high-resolution co...
Rebecca Mura,Svitlana Pochepnia,Daria Kifjak et al.
Rebecca Mura et al.
Mediastinal masses represent a heterogeneous group of entities characterized by a variety of histopathological and radiological features. Imaging plays a pivotal role in the detection and interpretation of mediastinal abnormalities. CT rema...
Being a radiation oncologist: times of crisis for European graduates [0.03%]
欧洲放射肿瘤学毕业生的危机时期：如何成为一名放射肿瘤学专家？
Federico Gagliardi,Emma D&#x;Ippolito,Roberta Grassi et al.
Federico Gagliardi et al.
This study examines the shortage of radiation oncologists in Italy and Europe, analysing systemic challenges in postgraduate training and proposing solutions to enhance the appeal of radiation oncology. A review of literature from Italy and...
A unified workflow for classifying patterns of locoregional failure using radiotherapy treatment planning dose distributions [0.03%]
基于放疗计划剂量分布的局部区域失败模式分类的统一工作流程
Ceilidh Welsh,Karl Harrison,Sara Lightowlers et al.
Ceilidh Welsh et al.
Objectives: This work describes a unified workflow for classifying patterns of locoregional recurrence (LRR) using radiotherapy planning dose distributions. This approach aims to incorporate dose parameters into LRR class...
Myelin mapping in patients with rheumatoid arthritis-related fatigue: a TBSS-MTR study of integrity [0.03%]
类风湿关节炎相关疲劳患者的髓鞘地图：TBSS-MTR完整性研究
Maryam Alhashim,Neil Basu,Alison Murray et al.
Maryam Alhashim et al.
Background: Rheumatoid arthritis (RA) patients frequently report fatigue, which notably diminishes their quality of life. Emerging research points to a correlation between inflammation-induced fatigue and brain structural...
Imaging patterns and recommendations for diagnosis, staging, and management of lung cancer [0.03%]
肺癌的诊断、分期和治疗的影像表现及建议
Nivedita Chakrabarty,Abhishek Mahajan,Nitin Shetty et al.
Nivedita Chakrabarty et al.
Lung cancer is the second most commonly diagnosed cancer worldwide. In the present era of targeted therapy for various lung cancer mutations, it is essential to be aware of the imaging correlates of various lung cancer mutations on contrast...
Understanding the variation of modern endoscopic ultrasound use in patients with oesophageal cancer (VALUE): protocol for a multi-methods study [0.03%]
VALUE研究：建立食管癌患者现代内镜超声使用差异的方法学研究方案
Kieran G Foley,Cherish Boxall,James Franklin et al.
Kieran G Foley et al.
Objectives: Over 9000 patients are diagnosed with oesophageal cancer annually in the United Kingdom (UK). Decision-making about treatment options is influenced by radiological staging, which may include computed tomograph...
The effects of anti-PD-1 therapy on programmed death-ligand 1 expression and glucose metabolism of normal organs in patients with advanced non-small cell lung cancer [0.03%]
抗PD-1治疗对晚期非小细胞肺癌患者正常器官programmed death-配体1表达及糖代谢的影响
Matthew Severyn,Eunice H L Lee,Gitasha Chand et al.
Matthew Severyn et al.
Objectives: To investigate how anti-PD-1 treatment affects both Programmed Death-Ligand 1 (PD-L1) expression and glucose metabolism within normal tissues of advanced non-small cell lung cancer (NSCLC) patients using a dua...